Table 2. Distribution of study population into low, moderate, and high cardiovascular risk categories.
| Age, years | Participants categorized by CVD risk n (%) | ||
|---|---|---|---|
| Low (< 10%) |
Moderate (10–< 20%) |
High (≥ 20%) |
|
| Male | |||
| Omani | |||
| 40–49 | 316 (94.0) | 10 (3.0) | 10 (3.0) |
| 50–59 | 84 (55.6) | 48 (31.8) | 19 (12.6) |
| 60–69 | 0 (0.0) | 44 (31.2) | 97 (68.8) |
| > 70 | 0 (0.0) | 0 (0.0) | 82 (100) |
| Total | 400 (56.3) | 102 (14.4) | 208 (29.3) |
| Non-Omani | |||
| 40–49 | 364 (95.0) | 10 (2.6) | 9 (2.3) |
| 50–59 | 77 (50.0) | 49 (31.8) | 28 (18.2) |
| 60–69 | 0 (0.0) | 7 (18.9) | 30 (81.1) |
| > 70 | 0 (0.0) | 0 (0.0) | 4 (100) |
| Total | 441 (76.3) | 66 (11.4) | 71 (12.3) |
| Female | |||
| Omani | |||
| 40–49 | 470 (93.6) | 25 (5.0) | 7 (1.4) |
| 50–59 | 233 (74.0) | 41 (13.0) | 41 (13.0) |
| 60–69 | 0 (0.0) | 55 (28.2) | 140 (71.8) |
| > 70 | 0 (0.0) | 0 (0.0) | 101 (100) |
| Total | 703 (63.2) | 121 (10.9) | 289 (26.0) |
| Non-Omani | |||
| 40–49 | 67 (89.3) | 6 (8.0) | 2 (2.7) |
| 50–59 | 19 (76.0) | 1 (4.0) | 5 (20.0) |
| 60–69 | 0 (0.0) | 0 (0.0) | 9 (100) |
| > 70 | - | - | - |
| Total | 86 (78.9) | 7 (6.4) | 16 (14.7) |
| Total | |||
| Omani | |||
| 40–49 | 786 (93.8) | 35 (4.2) | 17 (2.0) |
| 50–59 | 317 (68.0) | 89 (19.1) | 60 (12.9) |
| 60–69 | 0 (0.0) | 99 (29.5) | 237 (70.5) |
| > 70 | 0 (0.0) | 0 (0.0) | 183 (100) |
| Total | 1103 (60.5) | 223 (12.2) | 497 (27.3) |
| Non-Omani | |||
| 40–49 | 431 (94.1) | 16 (3.5) | 11 (2.4) |
| 50–59 | 96 (53.6) | 50 (27.9) | 33 (18.4) |
| 60–69 | 0 (0.0) | 7 (15.2) | 39 (84.8) |
| > 70 | 0 (0.0) | 0 (0.0) | 4 (100) |
| Total | 527 (76.7) | 73 (10.6) | 87 (12.7) |
| Overall total | 1630 (64.9) | 296 (11.8) | 584 (23.3) |
CVD: cardiovascular disease.